A5035776688- Pulmonary Hypertension Research and Treatments
- Nitric Oxide and Endothelin Effects
- Eicosanoids and Hypertension Pharmacology
- Congenital Heart Disease Studies
- Cardiac Health and Mental Health
- Cardiovascular Issues in Pregnancy
- Glutathione Transferases and Polymorphisms
- Tryptophan and brain disorders
- Biomedical Text Mining and Ontologies
- Liver Disease and Transplantation
- Neuroscience of respiration and sleep
- Vascular Anomalies and Treatments
- Sulfur Compounds in Biology
- Apelin-related biomedical research
- Medical and Biological Ozone Research
- Electrospun Nanofibers in Biomedical Applications
- Tissue Engineering and Regenerative Medicine
- Hydrogen's biological and therapeutic effects
- Hormonal Regulation and Hypertension
- Healthcare Systems and Public Health
- Biochemical effects in animals
- Cardiovascular Disease and Adiposity
- Chemical Reactions and Isotopes
LMU Klinikum
2025
Ludwig-Maximilians-Universität München
2025
Research Medical Center
2023
Institute of Experimental Cardiology
2012-2018
National Medical Research Center of Cardiology
2017
Ministry of Health of the Russian Federation
2012
Despite advancements in surgical techniques, many patients born with congenital heart defects (CHD) require repeated reinterventions due to the limitations of materials used cardiac surgery (CCS). Traditional biogenic polymers, such as bovine or equine pericardium, are prone calcification, have limited durability, and fail adapt growth infants. This study aims address these challenges by investigating bacterial cellulose (BC) a promising material for CCS. Variability patch quality from...
To study demographic and clinical characteristics to give a comparative description of the functional hemodynamic status, profile concomitant pathology in patients with various forms pulmonary arterial hypertension (PAH), chronic thromboembolic (CTEPH) according Russian National Registry.During period from January 01, 2012, till 2019, 1105 aged >18 years verified diagnosis PAH CTEPH, who were subsequently observed at 15 PH expert centers Federation 52 provinces, are included registry on...
The pandemic of a new coronavirus infection – COVID-19 («Coronavirus disease 2019») has changed the routine management patients with pulmonary arterial hypertension (PAH). Like other chronic cardiovascular diseases, PAH are not at higher risk infection. However, in current epidemiological situation, problems managing high-risk groups sharply indicated, which severe course lethality is more often noted. Undoubtedly, рatients different forms belong to group, considering both presence...
This clinical case illustrates the diagnosis of a rare congenital pathology – an adult patient with pulmonary arterial hypertension and Abernethy malformation type Ib. Clinical observation: Patient S., 45 years old, hypertension, was admitted complaints shortness breath during intense physical exertion. Based on anamnesis morbi, idiopathic has been verified since 2017. Results comprehensive examination: functional status (six-minute walk test), NTpro-BNP level, chest x-ray, echocardiography,...
Pulmonary arterial hypertension (PAH), associated with congenital heart disease (CHD) (PAH-CHD), despite the similarities of histological lesions, is а different from other forms PAH. PAH-CHD represented by a heterogeneous patient population varying defect locations, concomitant diseases, indications and contraindications to surgical correction; also, some patients have history closure. According European guidelines for diagnosis treatment pulmonary 2015, there are four main groups in...
Introduction. Since 2000 th CHD morbidity in Russia is growing constantly, especially, angina pectoris morbidity. Increasing workload on physicians due to high number of patients makes us find the ways optimize human resource applying. One possible development clinical decision support systems, particularly, ontology-based systems. These ontologies must adopt semantic interoperability for concepts included, be clearly interpreted by different medical schools. Research target. Develop...
<h3></h3> Современные подходы к лечению пациентов с легочной артериальной гипертензией (ЛАГ) — редким заболеванием неблагоприятным прогнозом, включают применение специфических вазодилататоров, механизм действия которых направлен на один из путей патогенеза этого заболевания. Эндогенный оксид азота (NO) одна важнейших молекул широкой палитрой воздействия тонус сосудов, тромбоцитарную и лейкоцитарную активность, пролиферацию гладкомышечных клеток фибробластов, а также воспалительный иммунный...